Yao-Ling Qiu,Hui Cao,Wei Li,Xiaowen Peng,Meizhong Jin,Jorden Kass,Xuri Gao,Yat Sun Or
申请号：
US16204166
公开号：
US20190216808A1
申请日:
2018.11.29
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
